

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 5.18003941 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 4.40644572 |
| 3 | central nervous system myelination (GO:0022010) | 4.39042290 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 4.39042290 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.38778886 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38778886 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 3.88444720 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.88444720 |
| 9 | aldehyde catabolic process (GO:0046185) | 3.82198091 |
| 10 | cholesterol biosynthetic process (GO:0006695) | 3.76589954 |
| 11 | B cell mediated immunity (GO:0019724) | 3.76172684 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.66516488 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.55539271 |
| 14 | response to peptidoglycan (GO:0032494) | 3.49473369 |
| 15 | very long-chain fatty acid metabolic process (GO:0000038) | 3.47000621 |
| 16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45056040 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37905158 |
| 18 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.37484621 |
| 19 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.37397712 |
| 20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.36128688 |
| 21 | nucleotide transmembrane transport (GO:1901679) | 3.35989537 |
| 22 | positive regulation of mast cell degranulation (GO:0043306) | 3.32318335 |
| 23 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.32318335 |
| 24 | sterol biosynthetic process (GO:0016126) | 3.31787980 |
| 25 | positive regulation of mast cell activation (GO:0033005) | 3.28083459 |
| 26 | glyoxylate metabolic process (GO:0046487) | 3.27575257 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.27384540 |
| 28 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.26400149 |
| 29 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.24855497 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.22025976 |
| 31 | ribosomal small subunit assembly (GO:0000028) | 3.14903468 |
| 32 | detection of other organism (GO:0098543) | 3.13920168 |
| 33 | proteasome assembly (GO:0043248) | 3.11530236 |
| 34 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.11256290 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.10431927 |
| 36 | amyloid precursor protein catabolic process (GO:0042987) | 3.10389645 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.07660213 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.07364943 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.06146832 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 3.02323809 |
| 41 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.01636278 |
| 42 | protein targeting to ER (GO:0045047) | 3.00611201 |
| 43 | detection of bacterium (GO:0016045) | 2.99929585 |
| 44 | viral transcription (GO:0019083) | 2.98713873 |
| 45 | oligosaccharide catabolic process (GO:0009313) | 2.97232527 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92224769 |
| 47 | ATP synthesis coupled proton transport (GO:0015986) | 2.92067492 |
| 48 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.92067492 |
| 49 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.89319858 |
| 50 | acyl-CoA biosynthetic process (GO:0071616) | 2.88960017 |
| 51 | thioester biosynthetic process (GO:0035384) | 2.88960017 |
| 52 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.88468168 |
| 53 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.88158908 |
| 54 | short-chain fatty acid metabolic process (GO:0046459) | 2.87133505 |
| 55 | protein localization to endoplasmic reticulum (GO:0070972) | 2.86172916 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85976580 |
| 57 | translational termination (GO:0006415) | 2.84955075 |
| 58 | regulation of mast cell degranulation (GO:0043304) | 2.84283819 |
| 59 | cysteine metabolic process (GO:0006534) | 2.84276552 |
| 60 | amyloid precursor protein metabolic process (GO:0042982) | 2.84248688 |
| 61 | tryptophan metabolic process (GO:0006568) | 2.82194925 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81121339 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81121339 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.81121339 |
| 65 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81121339 |
| 66 | modulation by symbiont of host defense response (GO:0052031) | 2.81121339 |
| 67 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81121339 |
| 68 | acyl-CoA metabolic process (GO:0006637) | 2.80806895 |
| 69 | thioester metabolic process (GO:0035383) | 2.80806895 |
| 70 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.80233325 |
| 71 | tyrosine metabolic process (GO:0006570) | 2.78953824 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 2.78709339 |
| 73 | indolalkylamine catabolic process (GO:0046218) | 2.78709339 |
| 74 | tryptophan catabolic process (GO:0006569) | 2.78709339 |
| 75 | isoprenoid biosynthetic process (GO:0008299) | 2.78698186 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 2.78549514 |
| 77 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.78170410 |
| 78 | cofactor catabolic process (GO:0051187) | 2.78128806 |
| 79 | drug transmembrane transport (GO:0006855) | 2.77708675 |
| 80 | alpha-linolenic acid metabolic process (GO:0036109) | 2.77314475 |
| 81 | regulation of mast cell activation (GO:0033003) | 2.77152254 |
| 82 | regulation of antigen processing and presentation (GO:0002577) | 2.76958695 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 2.75913065 |
| 84 | cellular response to interferon-gamma (GO:0071346) | 2.73222853 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70546209 |
| 86 | response to lipoprotein particle (GO:0055094) | 2.70218263 |
| 87 | regulation of hypersensitivity (GO:0002883) | 2.69363288 |
| 88 | cell wall macromolecule catabolic process (GO:0016998) | 2.68653523 |
| 89 | glutathione derivative metabolic process (GO:1901685) | 2.68480271 |
| 90 | glutathione derivative biosynthetic process (GO:1901687) | 2.68480271 |
| 91 | glycerophospholipid catabolic process (GO:0046475) | 2.66618483 |
| 92 | detection of external biotic stimulus (GO:0098581) | 2.65849880 |
| 93 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65559275 |
| 94 | neutrophil activation (GO:0042119) | 2.65527502 |
| 95 | response to interferon-beta (GO:0035456) | 2.65097946 |
| 96 | peptide catabolic process (GO:0043171) | 2.64711441 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.64387555 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63460749 |
| 99 | granulocyte activation (GO:0036230) | 2.63267608 |
| 100 | fatty acid beta-oxidation (GO:0006635) | 2.62134031 |
| 101 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.61779355 |
| 102 | bile acid metabolic process (GO:0008206) | 2.61079138 |
| 103 | glycosphingolipid catabolic process (GO:0046479) | 2.60632091 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 2.59190775 |
| 105 | fatty acid catabolic process (GO:0009062) | 2.58622584 |
| 106 | uronic acid metabolic process (GO:0006063) | 2.58554062 |
| 107 | glucuronate metabolic process (GO:0019585) | 2.58554062 |
| 108 | response to phenylpropanoid (GO:0080184) | 2.57966809 |
| 109 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.57653067 |
| 110 | complement activation, alternative pathway (GO:0006957) | 2.57357244 |
| 111 | B cell receptor signaling pathway (GO:0050853) | 2.56810949 |
| 112 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.56591642 |
| 113 | adhesion of symbiont to host cell (GO:0044650) | 2.56189118 |
| 114 | virion attachment to host cell (GO:0019062) | 2.56189118 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55169915 |
| 116 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.55116796 |
| 117 | protein carboxylation (GO:0018214) | 2.54470889 |
| 118 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54470889 |
| 119 | coenzyme catabolic process (GO:0009109) | 2.54340639 |
| 120 | cholesterol efflux (GO:0033344) | 2.54301180 |
| 121 | aromatic amino acid family metabolic process (GO:0009072) | 2.54030883 |
| 122 | creatine metabolic process (GO:0006600) | 2.53541013 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 2.53174349 |
| 124 | opsonization (GO:0008228) | 2.52267015 |
| 125 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.52252296 |
| 126 | histamine secretion (GO:0001821) | 2.51310638 |
| 127 | response to interferon-gamma (GO:0034341) | 2.51196122 |
| 128 | amine catabolic process (GO:0009310) | 2.49746115 |
| 129 | cellular biogenic amine catabolic process (GO:0042402) | 2.49746115 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.49637220 |
| 131 | lipid oxidation (GO:0034440) | 2.49619291 |
| 132 | fatty acid oxidation (GO:0019395) | 2.49550167 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.49211096 |
| 134 | regulation of cholesterol esterification (GO:0010872) | 2.48896433 |
| 135 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.48716656 |
| 136 | amino sugar catabolic process (GO:0046348) | 2.48579156 |
| 137 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48249568 |
| 138 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47227162 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.44361598 |
| 140 | oxidative phosphorylation (GO:0006119) | 2.44109607 |
| 141 | glycolipid catabolic process (GO:0019377) | 2.43046806 |
| 142 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42708700 |
| 143 | regulation of triglyceride catabolic process (GO:0010896) | 2.42527974 |
| 144 | platelet dense granule organization (GO:0060155) | 2.42294442 |
| 145 | respiratory electron transport chain (GO:0022904) | 2.42057656 |
| 146 | ensheathment of neurons (GO:0007272) | 2.41653430 |
| 147 | axon ensheathment (GO:0008366) | 2.41653430 |
| 148 | myelination (GO:0042552) | 2.41595782 |
| 149 | regulation of B cell differentiation (GO:0045577) | 2.41192658 |
| 150 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.41157885 |
| 151 | monocarboxylic acid catabolic process (GO:0072329) | 2.40383835 |
| 152 | defense response to protozoan (GO:0042832) | 2.39982610 |
| 153 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.39319078 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 2.39222521 |
| 155 | negative regulation of protein localization to cell surface (GO:2000009) | 2.38952733 |
| 156 | regulation of tolerance induction (GO:0002643) | 2.37119385 |
| 157 | ketone body metabolic process (GO:1902224) | 2.36335365 |
| 158 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36247835 |
| 159 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36247835 |
| 160 | adhesion of symbiont to host (GO:0044406) | 2.35371906 |
| 161 | alkaloid metabolic process (GO:0009820) | 2.34772900 |
| 162 | fibrinolysis (GO:0042730) | 2.34712834 |
| 163 | nucleotide transport (GO:0006862) | 2.34687843 |
| 164 | signal peptide processing (GO:0006465) | 2.34371539 |
| 165 | indolalkylamine metabolic process (GO:0006586) | 2.34137193 |
| 166 | electron transport chain (GO:0022900) | 2.33906632 |
| 167 | regulation of cholesterol metabolic process (GO:0090181) | 2.33803383 |
| 168 | translational elongation (GO:0006414) | 2.33609841 |
| 169 | respiratory burst (GO:0045730) | 2.33539738 |
| 170 | import into cell (GO:0098657) | 2.32986369 |
| 171 | ethanol metabolic process (GO:0006067) | 2.32129661 |
| 172 | ethanol oxidation (GO:0006069) | 2.31180510 |
| 173 | deoxyribose phosphate catabolic process (GO:0046386) | 2.30265164 |
| 174 | cell wall macromolecule metabolic process (GO:0044036) | 2.29631018 |
| 175 | translational initiation (GO:0006413) | 2.29462155 |
| 176 | purine-containing compound salvage (GO:0043101) | 2.29438832 |
| 177 | sulfur amino acid catabolic process (GO:0000098) | 2.29207481 |
| 178 | steroid biosynthetic process (GO:0006694) | 2.28880246 |
| 179 | regulation of activation of Janus kinase activity (GO:0010533) | 2.28862024 |
| 180 | positive regulation of leukocyte degranulation (GO:0043302) | 2.28830871 |
| 181 | transcytosis (GO:0045056) | 2.28791622 |
| 182 | response to hydroperoxide (GO:0033194) | 2.27902554 |
| 183 | high-density lipoprotein particle remodeling (GO:0034375) | 2.27469167 |
| 184 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.27411318 |
| 185 | cellular glucuronidation (GO:0052695) | 2.26882219 |
| 186 | heme transport (GO:0015886) | 2.26648276 |
| 187 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.26189705 |
| 188 | ribosomal large subunit biogenesis (GO:0042273) | 2.25386296 |
| 189 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.25010552 |
| 190 | detection of biotic stimulus (GO:0009595) | 2.24797388 |
| 191 | regulation of gamma-delta T cell activation (GO:0046643) | 2.24748447 |
| 192 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.24446936 |
| 193 | response to protozoan (GO:0001562) | 2.24166704 |
| 194 | cholesterol metabolic process (GO:0008203) | 2.23232200 |
| 195 | L-ascorbic acid metabolic process (GO:0019852) | 2.23027606 |
| 196 | regulation of T cell tolerance induction (GO:0002664) | 2.22873369 |
| 197 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.22730721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.93611842 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.36845392 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35768654 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.22998122 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.19307296 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.02383687 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.93375181 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.86587339 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.70257365 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66363841 |
| 11 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.61545392 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34386890 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.27700484 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27309133 |
| 15 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.24182919 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22512022 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.21960933 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.20886929 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.14193561 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09406404 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03572233 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96174951 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.94490743 |
| 24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.92375122 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.91056003 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90759393 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89585180 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89499430 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.84840413 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.82708964 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81369474 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.80109472 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.80109472 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77615873 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.72894380 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70708176 |
| 37 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.67470725 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66685921 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66028242 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64313008 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63689401 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59688279 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56679490 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55666290 |
| 45 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55019705 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.53299759 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52774277 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52014798 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50386336 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.49951672 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49024994 |
| 52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48507137 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47051945 |
| 54 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44305777 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42968735 |
| 56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40869674 |
| 57 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40230406 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39981724 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38665823 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38151007 |
| 61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37536334 |
| 62 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34785890 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34084987 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34024700 |
| 65 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33958017 |
| 66 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.32689477 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31680614 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31051050 |
| 69 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30417552 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28800366 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27718423 |
| 72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27268453 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26942722 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26441550 |
| 75 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25328066 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.22645238 |
| 77 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20624779 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20554136 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.20488992 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19206229 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17976696 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.16330207 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15800775 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15295281 |
| 85 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15129787 |
| 86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13496574 |
| 87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12025473 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11686795 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09792927 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09124248 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07522813 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07319209 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05187202 |
| 94 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04490217 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03657853 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01921487 |
| 97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00788482 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00391414 |
| 99 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98900614 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98863091 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97944950 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97560181 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97557734 |
| 104 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97201565 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95244474 |
| 106 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.95129263 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94807508 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94709620 |
| 109 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94457299 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94141678 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93778850 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.93496846 |
| 113 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93050537 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93044480 |
| 115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92242858 |
| 116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92098438 |
| 117 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91856603 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90912108 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90363622 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90305836 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90205421 |
| 122 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90205421 |
| 123 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.90145077 |
| 124 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.90022262 |
| 125 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89807905 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89559379 |
| 127 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.89131790 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89076929 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88273214 |
| 130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88187098 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.88178991 |
| 132 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88041536 |
| 133 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88012544 |
| 134 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87531264 |
| 135 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.87307713 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87260720 |
| 137 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.87072881 |
| 138 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87041292 |
| 139 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87002552 |
| 140 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86718886 |
| 141 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86416866 |
| 142 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86331343 |
| 143 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.85613403 |
| 144 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85350001 |
| 145 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85340014 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85089966 |
| 147 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84669367 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84009600 |
| 149 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82490414 |
| 150 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.82489339 |
| 151 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.82462154 |
| 152 | FUS_26573619_Chip-Seq_HEK293_Human | 0.82350244 |
| 153 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82175305 |
| 154 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82155048 |
| 155 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81854351 |
| 156 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.81739429 |
| 157 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81597808 |
| 158 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.81337766 |
| 159 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.81217655 |
| 160 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.80631714 |
| 161 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80495495 |
| 162 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80457271 |
| 163 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.80408756 |
| 164 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80301630 |
| 165 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.79796092 |
| 166 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.79796092 |
| 167 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79350293 |
| 168 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79256298 |
| 169 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78627871 |
| 170 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.78255379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.57930753 |
| 2 | MP0005360_urolithiasis | 4.03787839 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.30079791 |
| 4 | MP0003195_calcinosis | 3.23308420 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.04278351 |
| 6 | MP0005365_abnormal_bile_salt | 3.02069701 |
| 7 | MP0000920_abnormal_myelination | 2.71936245 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.69494214 |
| 9 | MP0003690_abnormal_glial_cell | 2.64644467 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.54003362 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.53425306 |
| 12 | MP0003303_peritoneal_inflammation | 2.47062333 |
| 13 | MP0001800_abnormal_humoral_immune | 2.45013490 |
| 14 | MP0003724_increased_susceptibility_to | 2.42995226 |
| 15 | MP0006054_spinal_hemorrhage | 2.35918782 |
| 16 | MP0009840_abnormal_foam_cell | 2.31296680 |
| 17 | MP0000685_abnormal_immune_system | 2.30177679 |
| 18 | MP0002132_abnormal_respiratory_system | 2.26082126 |
| 19 | MP0005451_abnormal_body_composition | 2.17919530 |
| 20 | MP0006082_CNS_inflammation | 2.17771924 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.06047985 |
| 22 | MP0005083_abnormal_biliary_tract | 2.03506259 |
| 23 | MP0005332_abnormal_amino_acid | 2.03300437 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.02576840 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.94748881 |
| 26 | MP0001819_abnormal_immune_cell | 1.94522595 |
| 27 | MP0001853_heart_inflammation | 1.93575714 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.88708823 |
| 29 | MP0003252_abnormal_bile_duct | 1.86001478 |
| 30 | MP0003186_abnormal_redox_activity | 1.79525133 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.69605962 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.69450419 |
| 33 | MP0005408_hypopigmentation | 1.64591963 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.64504927 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.61107152 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.58360821 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.58226062 |
| 38 | MP0009785_altered_susceptibility_to | 1.56905137 |
| 39 | MP0000604_amyloidosis | 1.56527680 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.53490307 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.50685899 |
| 42 | MP0002419_abnormal_innate_immunity | 1.49708735 |
| 43 | MP0009764_decreased_sensitivity_to | 1.47929500 |
| 44 | MP0004147_increased_porphyrin_level | 1.46934272 |
| 45 | MP0000716_abnormal_immune_system | 1.45882232 |
| 46 | MP0002405_respiratory_system_inflammati | 1.45386824 |
| 47 | MP0005171_absent_coat_pigmentation | 1.44590120 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.40014622 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.39072107 |
| 50 | MP0004043_abnormal_pH_regulation | 1.37091082 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.36985264 |
| 52 | MP0009697_abnormal_copulation | 1.36375836 |
| 53 | MP0005310_abnormal_salivary_gland | 1.34900880 |
| 54 | MP0001835_abnormal_antigen_presentation | 1.34744623 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.34250637 |
| 56 | MP0002398_abnormal_bone_marrow | 1.32967483 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32302151 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.31126641 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.30592756 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.22378832 |
| 61 | MP0002254_reproductive_system_inflammat | 1.21826751 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.19461629 |
| 63 | MP0008260_abnormal_autophagy | 1.19422018 |
| 64 | MP0001905_abnormal_dopamine_level | 1.18385848 |
| 65 | MP0008469_abnormal_protein_level | 1.18085101 |
| 66 | MP0005025_abnormal_response_to | 1.16693142 |
| 67 | MP0002429_abnormal_blood_cell | 1.15172772 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.14657162 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.13115228 |
| 70 | MP0002722_abnormal_immune_system | 1.12893217 |
| 71 | MP0000609_abnormal_liver_physiology | 1.12621677 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.12470780 |
| 73 | MP0001879_abnormal_lymphatic_vessel | 1.10812123 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.10483997 |
| 75 | MP0001764_abnormal_homeostasis | 1.08907017 |
| 76 | MP0000858_altered_metastatic_potential | 1.07646317 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.07343176 |
| 78 | MP0003329_amyloid_beta_deposits | 1.04771599 |
| 79 | MP0005164_abnormal_response_to | 1.04549689 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 1.03660112 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.03227619 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.03227619 |
| 83 | MP0000465_gastrointestinal_hemorrhage | 1.02221070 |
| 84 | MP0005387_immune_system_phenotype | 1.01437334 |
| 85 | MP0001790_abnormal_immune_system | 1.01437334 |
| 86 | MP0003011_delayed_dark_adaptation | 1.01113168 |
| 87 | MP0002876_abnormal_thyroid_physiology | 1.00951141 |
| 88 | MP0010368_abnormal_lymphatic_system | 0.99684954 |
| 89 | MP0003436_decreased_susceptibility_to | 0.99077769 |
| 90 | MP0003868_abnormal_feces_composition | 0.98929800 |
| 91 | MP0008004_abnormal_stomach_pH | 0.95926200 |
| 92 | MP0000343_altered_response_to | 0.95018296 |
| 93 | MP0005535_abnormal_body_temperature | 0.94734861 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.93651333 |
| 95 | MP0002006_tumorigenesis | 0.92926935 |
| 96 | MP0003136_yellow_coat_color | 0.92752757 |
| 97 | MP0003763_abnormal_thymus_physiology | 0.92210181 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.91936214 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.90399882 |
| 100 | MP0008995_early_reproductive_senescence | 0.88688333 |
| 101 | MP0003634_abnormal_glial_cell | 0.87110741 |
| 102 | MP0009763_increased_sensitivity_to | 0.85137569 |
| 103 | MP0003448_altered_tumor_morphology | 0.84987435 |
| 104 | MP0003786_premature_aging | 0.83565786 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.81764504 |
| 106 | MP0004742_abnormal_vestibular_system | 0.80208259 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.79229381 |
| 108 | MP0001661_extended_life_span | 0.77528132 |
| 109 | MP0001542_abnormal_bone_strength | 0.77422884 |
| 110 | MP0003075_altered_response_to | 0.76947341 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.76122535 |
| 112 | MP0004381_abnormal_hair_follicle | 0.75449777 |
| 113 | MP0010386_abnormal_urinary_bladder | 0.75445276 |
| 114 | MP0001756_abnormal_urination | 0.73594608 |
| 115 | MP0003828_pulmonary_edema | 0.73484989 |
| 116 | MP0005165_increased_susceptibility_to | 0.73365942 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.73188201 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.72298127 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.71297587 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.71147148 |
| 121 | MP0005409_darkened_coat_color | 0.69711300 |
| 122 | MP0002723_abnormal_immune_serum | 0.69704110 |
| 123 | MP0005166_decreased_susceptibility_to | 0.69650347 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.69078962 |
| 125 | MP0005647_abnormal_sex_gland | 0.68609759 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.68574462 |
| 127 | MP0002163_abnormal_gland_morphology | 0.68421119 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.67930926 |
| 129 | MP0000249_abnormal_blood_vessel | 0.67539283 |
| 130 | MP0004130_abnormal_muscle_cell | 0.66545858 |
| 131 | MP0005671_abnormal_response_to | 0.66468809 |
| 132 | MP0002009_preneoplasia | 0.66147230 |
| 133 | MP0002971_abnormal_brown_adipose | 0.66082109 |
| 134 | MP0009379_abnormal_foot_pigmentation | 0.65450291 |
| 135 | MP0002090_abnormal_vision | 0.65199316 |
| 136 | MP0002229_neurodegeneration | 0.63059921 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.63034683 |
| 138 | MP0003633_abnormal_nervous_system | 0.62906875 |
| 139 | MP0004883_abnormal_blood_vessel | 0.61987169 |
| 140 | MP0002452_abnormal_antigen_presenting | 0.61201107 |
| 141 | MP0001851_eye_inflammation | 0.60529958 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.59535237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.96475435 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.96475435 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.96475435 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.90611737 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.74694244 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.52862696 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.51305387 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.46408774 |
| 9 | Parakeratosis (HP:0001036) | 3.42220535 |
| 10 | Xanthomatosis (HP:0000991) | 3.26710908 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.21617165 |
| 12 | Disinhibition (HP:0000734) | 3.18656377 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.04753585 |
| 14 | Deep venous thrombosis (HP:0002625) | 2.98567681 |
| 15 | Complement deficiency (HP:0004431) | 2.97093173 |
| 16 | Nausea (HP:0002018) | 2.96309142 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.89882690 |
| 18 | Recurrent sinusitis (HP:0011108) | 2.84695499 |
| 19 | Axonal loss (HP:0003447) | 2.82159157 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78664287 |
| 21 | Joint hemorrhage (HP:0005261) | 2.78116024 |
| 22 | Petechiae (HP:0000967) | 2.73194215 |
| 23 | Cerebral hemorrhage (HP:0001342) | 2.71799947 |
| 24 | Fat malabsorption (HP:0002630) | 2.70950918 |
| 25 | Acute encephalopathy (HP:0006846) | 2.70487573 |
| 26 | Glomerulonephritis (HP:0000099) | 2.69281392 |
| 27 | Abnormality of glycolysis (HP:0004366) | 2.67582230 |
| 28 | Increased serum pyruvate (HP:0003542) | 2.67582230 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65891489 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.64739626 |
| 31 | Obstructive lung disease (HP:0006536) | 2.63865634 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.63865634 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.62753461 |
| 34 | Abnormality of urine glucose concentration (HP:0011016) | 2.61383188 |
| 35 | Glycosuria (HP:0003076) | 2.61383188 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.61377451 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 2.61326490 |
| 38 | Vasculitis (HP:0002633) | 2.58613475 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57147692 |
| 40 | Steatorrhea (HP:0002570) | 2.55637644 |
| 41 | Recurrent abscess formation (HP:0002722) | 2.53131164 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.52352299 |
| 43 | Meningitis (HP:0001287) | 2.51599339 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.49836087 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.49276473 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.48693893 |
| 47 | Stomatitis (HP:0010280) | 2.45596434 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.44176589 |
| 49 | Hypoglycemic coma (HP:0001325) | 2.43778144 |
| 50 | Cerebral edema (HP:0002181) | 2.42028675 |
| 51 | Acute necrotizing encephalopathy (HP:0006965) | 2.41723292 |
| 52 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.41361396 |
| 53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.41361396 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.39720297 |
| 55 | Increased CSF lactate (HP:0002490) | 2.37720193 |
| 56 | Gastrointestinal stroma tumor (HP:0100723) | 2.36783400 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.35943114 |
| 58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35199964 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.32414731 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.32258411 |
| 61 | IgM deficiency (HP:0002850) | 2.31200475 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.30018760 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.30018760 |
| 64 | Ketosis (HP:0001946) | 2.29177085 |
| 65 | Hyperammonemia (HP:0001987) | 2.29089393 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29019010 |
| 67 | Hypomagnesemia (HP:0002917) | 2.28707551 |
| 68 | Dicarboxylic aciduria (HP:0003215) | 2.28594993 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.28594993 |
| 70 | Hypokalemic alkalosis (HP:0001949) | 2.28339181 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.27441213 |
| 72 | Macrocytic anemia (HP:0001972) | 2.27075859 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.26521835 |
| 74 | Loss of speech (HP:0002371) | 2.24164338 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24035431 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24035431 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.21456356 |
| 78 | Chronic diarrhea (HP:0002028) | 2.21306153 |
| 79 | Reticulocytopenia (HP:0001896) | 2.20329812 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.19916922 |
| 81 | Abnormality of renal resorption (HP:0011038) | 2.19502051 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.18731736 |
| 83 | Vascular calcification (HP:0004934) | 2.17132494 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16510239 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.15033251 |
| 86 | Myositis (HP:0100614) | 2.15022364 |
| 87 | Optic neuritis (HP:0100653) | 2.14366223 |
| 88 | Retrobulbar optic neuritis (HP:0100654) | 2.14366223 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.14034125 |
| 90 | Agammaglobulinemia (HP:0004432) | 2.12938431 |
| 91 | Spastic paraparesis (HP:0002313) | 2.12123992 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 2.11056787 |
| 93 | Abnormality of complement system (HP:0005339) | 2.10997492 |
| 94 | Sensory axonal neuropathy (HP:0003390) | 2.10705438 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.10616722 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.09931773 |
| 97 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09719794 |
| 98 | Methylmalonic aciduria (HP:0012120) | 2.09271078 |
| 99 | Recurrent skin infections (HP:0001581) | 2.08709876 |
| 100 | Recurrent bronchitis (HP:0002837) | 2.08675350 |
| 101 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.07131774 |
| 102 | Progressive macrocephaly (HP:0004481) | 2.06345483 |
| 103 | Epidermoid cyst (HP:0200040) | 2.06291529 |
| 104 | Recurrent viral infections (HP:0004429) | 2.06086480 |
| 105 | Lethargy (HP:0001254) | 2.05495640 |
| 106 | Recurrent pneumonia (HP:0006532) | 2.04883267 |
| 107 | Combined immunodeficiency (HP:0005387) | 2.04807328 |
| 108 | Hyperglycinuria (HP:0003108) | 2.03743445 |
| 109 | Malnutrition (HP:0004395) | 2.02544482 |
| 110 | Lymphopenia (HP:0001888) | 2.02102704 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01691473 |
| 112 | Increased circulating renin level (HP:0000848) | 2.01407563 |
| 113 | Hepatic necrosis (HP:0002605) | 2.00960144 |
| 114 | Alkalosis (HP:0001948) | 1.99546429 |
| 115 | Mutism (HP:0002300) | 1.98235117 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 1.98176424 |
| 117 | Mitochondrial inheritance (HP:0001427) | 1.97801287 |
| 118 | T lymphocytopenia (HP:0005403) | 1.97396758 |
| 119 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.97360997 |
| 120 | Prolonged neonatal jaundice (HP:0006579) | 1.96790622 |
| 121 | Encephalitis (HP:0002383) | 1.96788324 |
| 122 | Amyloidosis (HP:0011034) | 1.95328816 |
| 123 | Ketoacidosis (HP:0001993) | 1.95298546 |
| 124 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95158231 |
| 125 | Skin rash (HP:0000988) | 1.94783182 |
| 126 | Hemoptysis (HP:0002105) | 1.94754395 |
| 127 | Pulmonary fibrosis (HP:0002206) | 1.94380952 |
| 128 | Hypolipoproteinemia (HP:0010981) | 1.94380846 |
| 129 | Vomiting (HP:0002013) | 1.94169900 |
| 130 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.92776497 |
| 131 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.92652819 |
| 132 | Leukodystrophy (HP:0002415) | 1.92400112 |
| 133 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.92289917 |
| 134 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90739119 |
| 135 | Dysostosis multiplex (HP:0000943) | 1.90575576 |
| 136 | Orchitis (HP:0100796) | 1.89775904 |
| 137 | Hypercholesterolemia (HP:0003124) | 1.89528234 |
| 138 | Pustule (HP:0200039) | 1.89074899 |
| 139 | Bronchiectasis (HP:0002110) | 1.88140411 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88051720 |
| 141 | Urticaria (HP:0001025) | 1.87938817 |
| 142 | Neutropenia (HP:0001875) | 1.87497657 |
| 143 | Respiratory distress (HP:0002098) | 1.86969502 |
| 144 | Exertional dyspnea (HP:0002875) | 1.85568235 |
| 145 | Metabolic acidosis (HP:0001942) | 1.85129591 |
| 146 | Abnormality of T cell number (HP:0011839) | 1.85028793 |
| 147 | Rhinitis (HP:0012384) | 1.84182318 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.83832408 |
| 149 | Hyperglycinemia (HP:0002154) | 1.83602176 |
| 150 | Renal cortical cysts (HP:0000803) | 1.83451225 |
| 151 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83150861 |
| 152 | B lymphocytopenia (HP:0010976) | 1.82957337 |
| 153 | Cardiovascular calcification (HP:0011915) | 1.82456902 |
| 154 | Polyneuropathy (HP:0001271) | 1.81221130 |
| 155 | Peripheral demyelination (HP:0011096) | 1.80647838 |
| 156 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80067240 |
| 157 | Basal ganglia calcification (HP:0002135) | 1.79822545 |
| 158 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.79715849 |
| 159 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78400342 |
| 160 | Paraparesis (HP:0002385) | 1.77858718 |
| 161 | Inflammation of the large intestine (HP:0002037) | 1.77478035 |
| 162 | Purpura (HP:0000979) | 1.76908732 |
| 163 | Colitis (HP:0002583) | 1.76384427 |
| 164 | Abnormality of B cell number (HP:0010975) | 1.76245062 |
| 165 | Hypothermia (HP:0002045) | 1.76173568 |
| 166 | Respiratory failure (HP:0002878) | 1.75489118 |
| 167 | Hypoalphalipoproteinemia (HP:0003233) | 1.74161679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.38438142 |
| 2 | ACVR1B | 3.59718225 |
| 3 | PBK | 3.49134920 |
| 4 | OXSR1 | 3.31515027 |
| 5 | EPHB1 | 3.20263132 |
| 6 | MST4 | 3.02458079 |
| 7 | MAP4K2 | 2.45910602 |
| 8 | EIF2AK3 | 2.43851662 |
| 9 | MAP4K1 | 2.32903124 |
| 10 | TIE1 | 2.29618971 |
| 11 | WNK4 | 2.29092247 |
| 12 | MAP3K12 | 2.28582406 |
| 13 | MAP3K14 | 2.24470032 |
| 14 | NME2 | 2.22330384 |
| 15 | BCR | 2.12957220 |
| 16 | NEK1 | 2.09769151 |
| 17 | FGFR2 | 1.92794677 |
| 18 | TNIK | 1.88606902 |
| 19 | BLK | 1.71166162 |
| 20 | INSRR | 1.69566656 |
| 21 | TRIM28 | 1.64071507 |
| 22 | PDK2 | 1.63785461 |
| 23 | BMPR1B | 1.63372879 |
| 24 | IRAK3 | 1.62329192 |
| 25 | PKN1 | 1.58317590 |
| 26 | CSF1R | 1.52861506 |
| 27 | IRAK4 | 1.51224240 |
| 28 | GRK7 | 1.50539659 |
| 29 | BCKDK | 1.48592406 |
| 30 | MAPKAPK5 | 1.43540997 |
| 31 | MATK | 1.40471764 |
| 32 | CDK19 | 1.38021184 |
| 33 | MET | 1.37720686 |
| 34 | ERBB4 | 1.34315652 |
| 35 | PIK3CG | 1.33922682 |
| 36 | FRK | 1.33539531 |
| 37 | FES | 1.27448025 |
| 38 | BMPR2 | 1.25225830 |
| 39 | JAK3 | 1.23944937 |
| 40 | SYK | 1.23427350 |
| 41 | TGFBR1 | 1.21612964 |
| 42 | TBK1 | 1.21551724 |
| 43 | BTK | 1.19105095 |
| 44 | ZAK | 1.18644377 |
| 45 | IRAK2 | 1.14540398 |
| 46 | PASK | 1.13914339 |
| 47 | SIK3 | 1.11988402 |
| 48 | IRAK1 | 1.11845102 |
| 49 | MAPK15 | 1.11471028 |
| 50 | CSNK1G3 | 1.09913112 |
| 51 | TGFBR2 | 1.09585116 |
| 52 | IKBKE | 1.08162866 |
| 53 | MST1R | 1.07450937 |
| 54 | FGR | 1.04569329 |
| 55 | ABL2 | 1.04264624 |
| 56 | KDR | 1.03369386 |
| 57 | NUAK1 | 1.03083119 |
| 58 | ERBB3 | 1.01597285 |
| 59 | CASK | 0.99236910 |
| 60 | PRKCQ | 0.98470411 |
| 61 | CSNK1A1L | 0.98167132 |
| 62 | CSNK1G1 | 0.96961169 |
| 63 | FLT3 | 0.94998758 |
| 64 | TAOK3 | 0.94492029 |
| 65 | FGFR4 | 0.92547059 |
| 66 | TYK2 | 0.91517434 |
| 67 | IKBKB | 0.90887712 |
| 68 | OBSCN | 0.90492910 |
| 69 | TRPM7 | 0.90303104 |
| 70 | RIPK4 | 0.89934419 |
| 71 | SGK223 | 0.89099018 |
| 72 | SGK494 | 0.89099018 |
| 73 | WNK1 | 0.88448853 |
| 74 | BUB1 | 0.88280249 |
| 75 | PRKCE | 0.88025270 |
| 76 | ADRBK2 | 0.87473968 |
| 77 | MKNK1 | 0.86511281 |
| 78 | MYLK | 0.85951175 |
| 79 | GRK1 | 0.85729455 |
| 80 | HCK | 0.82886024 |
| 81 | STK16 | 0.82619146 |
| 82 | NEK9 | 0.81098700 |
| 83 | CSK | 0.80986756 |
| 84 | KIT | 0.80218435 |
| 85 | LIMK1 | 0.77909530 |
| 86 | EPHA3 | 0.77470498 |
| 87 | NEK6 | 0.77203820 |
| 88 | STK24 | 0.76447146 |
| 89 | ZAP70 | 0.75020881 |
| 90 | GRK6 | 0.72912272 |
| 91 | DYRK2 | 0.72867431 |
| 92 | CAMK2D | 0.72391536 |
| 93 | STK10 | 0.72333915 |
| 94 | RPS6KA4 | 0.71899861 |
| 95 | VRK1 | 0.71099479 |
| 96 | PLK4 | 0.70364430 |
| 97 | CSNK1G2 | 0.69005887 |
| 98 | MAP2K2 | 0.68253781 |
| 99 | TEC | 0.67704918 |
| 100 | NLK | 0.66854140 |
| 101 | MUSK | 0.66482764 |
| 102 | ARAF | 0.66112059 |
| 103 | GSK3A | 0.65615159 |
| 104 | JAK2 | 0.65610891 |
| 105 | PIK3CA | 0.65271767 |
| 106 | CAMK2B | 0.63392260 |
| 107 | TXK | 0.63055024 |
| 108 | ITK | 0.62420215 |
| 109 | MAP3K13 | 0.61540610 |
| 110 | CCNB1 | 0.60360800 |
| 111 | DYRK3 | 0.59888370 |
| 112 | CAMK2G | 0.59604924 |
| 113 | PRKAA2 | 0.59157171 |
| 114 | NTRK1 | 0.58139340 |
| 115 | EIF2AK1 | 0.56628786 |
| 116 | CAMKK2 | 0.56186043 |
| 117 | LYN | 0.55793811 |
| 118 | LRRK2 | 0.55183922 |
| 119 | CLK1 | 0.52080647 |
| 120 | VRK2 | 0.51682593 |
| 121 | ABL1 | 0.50659597 |
| 122 | CAMK2A | 0.50420222 |
| 123 | JAK1 | 0.49158223 |
| 124 | IGF1R | 0.48344607 |
| 125 | MKNK2 | 0.47907154 |
| 126 | PTK2B | 0.47381049 |
| 127 | ROCK2 | 0.46400713 |
| 128 | WNK3 | 0.46097609 |
| 129 | PRKG2 | 0.45030795 |
| 130 | LCK | 0.44843801 |
| 131 | PRKD1 | 0.43998890 |
| 132 | PINK1 | 0.43897080 |
| 133 | PDPK1 | 0.43504078 |
| 134 | PRPF4B | 0.43471047 |
| 135 | MOS | 0.42912820 |
| 136 | BRSK2 | 0.42628437 |
| 137 | NEK2 | 0.42506586 |
| 138 | PRKCD | 0.42423662 |
| 139 | PRKG1 | 0.42167204 |
| 140 | PLK3 | 0.42083173 |
| 141 | CHUK | 0.40952490 |
| 142 | YES1 | 0.40637994 |
| 143 | MAP3K5 | 0.40607649 |
| 144 | AKT3 | 0.39705449 |
| 145 | GRK5 | 0.39280948 |
| 146 | CSNK2A1 | 0.38983944 |
| 147 | EGFR | 0.38027335 |
| 148 | MAP3K10 | 0.37511716 |
| 149 | MARK3 | 0.37328684 |
| 150 | EIF2AK2 | 0.36616801 |
| 151 | MAP3K3 | 0.36487942 |
| 152 | STK3 | 0.35877241 |
| 153 | TNK2 | 0.33317912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.27837914 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.26963151 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.23646801 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.00003718 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.77178390 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.74582987 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67616305 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.48662113 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46768274 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36008517 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35681505 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31734492 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.22465320 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.15732020 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.11439849 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07854754 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05499041 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04685461 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99061955 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94121308 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.91828857 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89428812 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.83408970 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74230649 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72127603 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66631209 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64070613 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58501171 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58475007 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55837373 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.53717413 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49195786 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.45134065 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43362203 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42481071 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41040462 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40651488 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38945739 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37472803 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26594016 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26542023 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22898491 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.22194012 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20376968 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15969250 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.15686425 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.13796262 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08262962 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06904781 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06283582 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05856215 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04668228 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03928715 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03878802 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03591800 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01941704 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99213141 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99096915 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98604825 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97769207 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97416664 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97086535 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95542179 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94931045 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94207760 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94138240 |
| 67 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93042680 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90057920 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.87668647 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87017626 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 0.86939467 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86799338 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.85673946 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.85144616 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.84810153 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.84739352 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84126137 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82815369 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77913845 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.77150276 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74760089 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.73869370 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73046801 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72751740 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71501043 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71443691 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.71439810 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.70648355 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69725394 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67963751 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67386725 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.66414488 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65611965 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.64959211 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62532418 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61778676 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61152955 |
| 98 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60527018 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59533165 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59139562 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59108387 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55196579 |
| 103 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53382191 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51660999 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47751680 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47153092 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.46705466 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45385613 |
| 109 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43300112 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43260930 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43123245 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43065097 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42612329 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.42015387 |
| 115 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41712434 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40730480 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39900277 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39578917 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38808616 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38738095 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.37310832 |
| 122 | RNA polymerase_Homo sapiens_hsa03020 | 0.36813604 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36568104 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36504626 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36228372 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34929290 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.34692657 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33984895 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33746449 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33566528 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32992148 |
| 132 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32673466 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32051533 |
| 134 | RNA transport_Homo sapiens_hsa03013 | 0.31348391 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.30985631 |
| 136 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30405757 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30300104 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.29767839 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29467731 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29135047 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.28119390 |

